Tachycardia in cancer patients could signal increased risk of mortality - European Pharmaceutical Review

Tachycardia in cancer patients could signal increased risk of mortality  European Pharmaceutical Review

A study has shown a link between tachycardia and an increased risk of mortality in cancer patients, even up to 10 years after diagnosis.



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more